BiotechTube
Home/Anavex Life Sciences/Daniel Klamer, PhD, MS, MBA
DK

Daniel Klamer, PhD, MS, MBA

Vice President of Business Development and Scientific Strategy

Anavex Life Sciences

Therapeutic Areas

Neurodegenerative DiseasesNeurodevelopmental Disorders

Anavex Life Sciences Pipeline

DrugIndicationPhase
Blarcamesine (ANAVEX®2-73)Alzheimer’s DiseasePhase 2b/3
ANAVEX®3-71SchizophreniaPhase 2
ANAVEX®1-41CNS DisordersPreclinical
ANAVEX®1066Not SpecifiedDiscovery/Preclinical

Leadership Team at Anavex Life Sciences

CU
Christopher U. Missling, PhD, MS, MBA
President and Chief Executive Officer
JC
Juan Carlos Lopez-Talavera, MD, PhD
Senior Vice President, Head of Research and Development
WL
Wolfgang Liedtke, MD, PhD
Senior Vice President, Global Head of Neurology
TK
Terrie Kellmeyer, PhD
Senior Vice President of Clinical Development
KJ
Kun Jin, PhD
Vice President and Head of Biostatistics
DA
Dr. Adebayo Laniyonu, PhD
Senior Vice President for Nonclinical Development
DM
Dr. Marwan N Sabbagh, MD
Scientific Advisor
View full Anavex Life Sciences profile